Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP549340.RArC4a6mMdfTOSf_-3pd9QaN2PbKnR3E9A-1F8UaEoLF4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP549340.RArC4a6mMdfTOSf_-3pd9QaN2PbKnR3E9A-1F8UaEoLF4130_assertion type Assertion NP549340.RArC4a6mMdfTOSf_-3pd9QaN2PbKnR3E9A-1F8UaEoLF4130_head.
- NP549340.RArC4a6mMdfTOSf_-3pd9QaN2PbKnR3E9A-1F8UaEoLF4130_assertion description "[These data provide further evidence that modulators of the NPY Y2 receptor subtype are drug targets for the treatment of anxiety and mood disorders in human subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549340.RArC4a6mMdfTOSf_-3pd9QaN2PbKnR3E9A-1F8UaEoLF4130_provenance.
- NP549340.RArC4a6mMdfTOSf_-3pd9QaN2PbKnR3E9A-1F8UaEoLF4130_assertion evidence source_evidence_literature NP549340.RArC4a6mMdfTOSf_-3pd9QaN2PbKnR3E9A-1F8UaEoLF4130_provenance.
- NP549340.RArC4a6mMdfTOSf_-3pd9QaN2PbKnR3E9A-1F8UaEoLF4130_assertion SIO_000772 16691011 NP549340.RArC4a6mMdfTOSf_-3pd9QaN2PbKnR3E9A-1F8UaEoLF4130_provenance.
- NP549340.RArC4a6mMdfTOSf_-3pd9QaN2PbKnR3E9A-1F8UaEoLF4130_assertion wasDerivedFrom befree-2016 NP549340.RArC4a6mMdfTOSf_-3pd9QaN2PbKnR3E9A-1F8UaEoLF4130_provenance.
- NP549340.RArC4a6mMdfTOSf_-3pd9QaN2PbKnR3E9A-1F8UaEoLF4130_assertion wasGeneratedBy ECO_0000203 NP549340.RArC4a6mMdfTOSf_-3pd9QaN2PbKnR3E9A-1F8UaEoLF4130_provenance.